ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Regulatory Approvals: Gardasil 9 approved, which covers five additional HPV types

December 12, 2014

NCI Cancer Center Support Grants Listed, 1989 vs. 1995

March 22, 1996

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

Four RFAs Released For RM Program

November 6, 1981

The March To Deliver Message Of Funding For Cancer Research, Access To Care

September 4, 1998